Share-based Payment Arrangement, Expense in USD of Fulgent Genetics, Inc. from 2015 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Fulgent Genetics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and change rate from 2015 to Q3 2025.
  • Fulgent Genetics, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $9.72M, a 11% decline year-over-year.
  • Fulgent Genetics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $40.7M, a 10.5% decline year-over-year.
  • Fulgent Genetics, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $44.5M, a 3.63% increase from 2023.
  • Fulgent Genetics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $42.9M, a 31.5% increase from 2022.
  • Fulgent Genetics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $32.6M, a 106% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Fulgent Genetics, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $40.7M $9.72M -$1.2M -11% 01 Jul 2025 30 Sep 2025 10-Q 07 Nov 2025
Q2 2025 $41.9M $10M -$1.6M -13.7% 01 Apr 2025 30 Jun 2025 10-Q 01 Aug 2025
Q1 2025 $43.5M $10.6M -$968K -8.4% 01 Jan 2025 31 Mar 2025 10-Q 02 May 2025
Q4 2024 $44.5M $10.4M -$1.02M -8.96% 01 Oct 2024 31 Dec 2024 10-K 28 Feb 2025
Q3 2024 $45.5M $10.9M +$18K +0.17% 01 Jul 2024 30 Sep 2024 10-Q 07 Nov 2025
Q2 2024 $45.5M $11.6M +$1.31M +12.7% 01 Apr 2024 30 Jun 2024 10-Q 01 Aug 2025
Q1 2024 $44.2M $11.5M +$1.25M +12.2% 01 Jan 2024 31 Mar 2024 10-Q 02 May 2025
Q4 2023 $42.9M $11.4M +$1.41M +14.1% 01 Oct 2023 31 Dec 2023 10-K 28 Feb 2025
Q3 2023 $41.5M $10.9M +$1.93M +21.5% 01 Jul 2023 30 Sep 2023 10-Q 08 Nov 2024
Q2 2023 $39.6M $10.3M +$2.29M +28.6% 01 Apr 2023 30 Jun 2023 10-Q 02 Aug 2024
Q1 2023 $37.3M $10.3M +$4.65M +82.8% 01 Jan 2023 31 Mar 2023 10-Q 03 May 2024
Q4 2022 $32.6M $10M +$5M +99.6% 01 Oct 2022 31 Dec 2022 10-K 28 Feb 2025
Q3 2022 $27.6M $8.97M +$4.6M +105% 01 Jul 2022 30 Sep 2022 10-Q 03 Nov 2023
Q2 2022 $23M $8.03M +$4.5M +128% 01 Apr 2022 30 Jun 2022 10-Q 04 Aug 2023
Q1 2022 $18.5M $5.62M +$2.65M +89.6% 01 Jan 2022 31 Mar 2022 10-Q 05 May 2023
Q4 2021 $15.9M $5.02M +$2.02M +67.2% 01 Oct 2021 31 Dec 2021 10-K 28 Feb 2024
Q3 2021 $13.9M $4.37M +$1.22M +38.9% 01 Jul 2021 30 Sep 2021 10-Q 07 Nov 2022
Q2 2021 $12.6M $3.53M +$2.45M +226% 01 Apr 2021 30 Jun 2021 10-Q 04 Aug 2022
Q1 2021 $10.2M $2.96M +$2.04M +221% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022
Q4 2020 $8.16M $3M +$2.07M +220% 01 Oct 2020 31 Dec 2020 10-K 28 Feb 2023
Q3 2020 $6.09M $3.15M +$2.2M +231% 01 Jul 2020 30 Sep 2020 10-Q 09 Nov 2021
Q2 2020 $3.89M $1.08M +$343K +46.5% 01 Apr 2020 30 Jun 2020 10-Q 10 Aug 2021
Q1 2020 $3.55M $924K +$341K +58.5% 01 Jan 2020 31 Mar 2020 10-Q 07 May 2021
Q4 2019 $3.21M $938K +$340K +56.9% 01 Oct 2019 31 Dec 2019 10-K 28 Feb 2022
Q3 2019 $2.87M $951K +$363K +61.7% 01 Jul 2019 30 Sep 2019 10-Q 09 Nov 2020
Q2 2019 $2.51M $737K +$164K +28.6% 01 Apr 2019 30 Jun 2019 10-Q 05 Aug 2020
Q1 2019 $2.34M $583K +$38K +6.97% 01 Jan 2019 31 Mar 2019 10-Q 06 May 2020
Q4 2018 $2.3M $598K +$17K +2.93% 01 Oct 2018 31 Dec 2018 10-K 13 Mar 2020
Q3 2018 $2.29M $588K +$39K +7.1% 01 Jul 2018 30 Sep 2018 10-Q 08 Nov 2019
Q2 2018 $2.25M $573K +$149K +35.1% 01 Apr 2018 30 Jun 2018 10-Q 12 Aug 2019
Q1 2018 $2.1M $545K -$20K -3.54% 01 Jan 2018 31 Mar 2018 10-Q 10 May 2019
Q4 2017 $2.12M $581K 01 Oct 2017 31 Dec 2017 10-K 22 Mar 2019
Q3 2017 $549K -$1.94M -78% 01 Jul 2017 30 Sep 2017 10-Q 09 Nov 2018
Q2 2017 $424K 01 Apr 2017 30 Jun 2017 10-Q 13 Aug 2018
Q1 2017 $565K -$1.06M -65.2% 01 Jan 2017 31 Mar 2017 10-Q 14 May 2018
Q3 2016 $2.49M 01 Jul 2016 30 Sep 2016 10-Q 13 Nov 2017
Q1 2016 $1.63M 01 Jan 2016 31 Mar 2016 10-Q 09 May 2017

Fulgent Genetics, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $44.5M +$1.56M +3.63% 01 Jan 2024 31 Dec 2024 10-K 28 Feb 2025
2023 $42.9M +$10.3M +31.5% 01 Jan 2023 31 Dec 2023 10-K 28 Feb 2025
2022 $32.6M +$16.8M +106% 01 Jan 2022 31 Dec 2022 10-K 28 Feb 2025
2021 $15.9M +$7.73M +94.7% 01 Jan 2021 31 Dec 2021 10-K 28 Feb 2024
2020 $8.16M +$4.95M +154% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2023
2019 $3.21M +$905K +39.3% 01 Jan 2019 31 Dec 2019 10-K 28 Feb 2022
2018 $2.3M +$185K +8.73% 01 Jan 2018 31 Dec 2018 10-K 13 Mar 2020
2017 $2.12M -$2.54M -54.5% 01 Jan 2017 31 Dec 2017 10-K 22 Mar 2019
2016 $4.65M -$3.5M -42.9% 01 Jan 2016 31 Dec 2016 10-K 20 Mar 2018
2015 $8.16M 01 Jan 2015 31 Dec 2015 10-K 17 Mar 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.